The effect of camel milk with Alhagi maurorum Medik on chronic kidney disease
Phase 2
- Conditions
- Condition 1: Chronic kidney disease, stage 1. Condition 2: Chronic kidney disease, stage 2. Condition 3: Chronic kidney disease, stage 3. Condition 4: Chronic kidney disease, stage 4.Kidney damage with normal or increased GFR (> 90 mL/min)Kidney damage with mild decreased GFR (60-89 mL/min)Kidney damage with moderately decreased GFR (30-59 mL/min)Kidney damage with severely decreased GFR (15-29 mL/min)
- Registration Number
- IRCT2016121531427N1
- Lead Sponsor
- Vice Chancellor for Research and Technology Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
patients with chronic kidney disease;
aged 15 to 70 years
Exclusion Criteria
Patients with chronic kidney disease concomitant uncontrolled diabetes(Hb A1c less than 9 and fasting blood sugar greater than 130)
Patients with uncontrolled hypertension(systolic blood pressure of 160 mm Hg and higher and diastolic blood pressure of 100 mm Hg and higher)
cancer patients
patients with urinary obstruction
the fifth stage of chronic kidney disease
patients with acute infection and feverish
patients who are taking nephrotoxic drugs
patients with heart failure
liver failure
poly cystic kidney
pregnancy
patients who had kidney transplant
drug addicts
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glomerular filtration rate. Timepoint: Before the intervention, the end of intervention. Method of measurement: Cockcroft gault Formula, MDRD.
- Secondary Outcome Measures
Name Time Method